Literature DB >> 26973310

Bedaquiline plus delamanid for XDR tuberculosis.

Marie Lachâtre1, Christophe Rioux2, Damien Le Dû3, Mathilde Fréchet-Jachym3, Nicolas Veziris4, Elisabeth Bouvet5, Yazdan Yazdanpanah6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26973310     DOI： 10.1016/S1473-3099(16)00047-5

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN： 1473-3099            Impact factor:   25.071


× No keyword cloud information.
  7 in total

Review 1.  Newer Drugs for Tuberculosis Prevention and Treatment in Children.

Authors:  Ben J Marais
Journal:  Indian J Pediatr       Date:  2019-02-01       Impact factor: 1.967

Review 2.  Recent developments in the diagnosis and management of tuberculosis.

Authors:  Giorgia Sulis; Rosella Centis; Giovanni Sotgiu; Lia D'Ambrosio; Emanuele Pontali; Antonio Spanevello; Alberto Matteelli; Alimuddin Zumla; Giovanni Battista Migliori
Journal:  NPJ Prim Care Respir Med       Date:  2016-11-03       Impact factor: 2.871

Review 3.  Clinical Implications of New Drugs and Regimens for the Treatment of Drug-resistant Tuberculosis.

Authors:  Yong-Soo Kwon
Journal:  Chonnam Med J       Date:  2017-05-25

Review 4.  Combined Use of Delamanid and Bedaquiline to Treat Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis: A Systematic Review.

Authors:  Giovanni Battista Migliori; Emanuele Pontali; Giovanni Sotgiu; Rosella Centis; Lia D'Ambrosio; Simon Tiberi; Marina Tadolini; Susanna Esposito
Journal:  Int J Mol Sci       Date:  2017-02-07       Impact factor: 5.923

5.  Bedaquiline and Delamanid Combination Treatment of 5 Patients with Pulmonary Extensively Drug-Resistant Tuberculosis.

Authors:  Andrey Maryandyshev; Emanuele Pontali; Simon Tiberi; Onno Akkerman; Shashank Ganatra; Tsetan Dorji Sadutshang; Jan-Willem Alffenaar; Rohit Amale; Jai Mullerpattan; Sonam Topgyal; Zarir Farokh Udwadia; Rosella Centis; Lia D'Ambrosio; Giovanni Sotgiu; Giovanni Battista Migliori
Journal:  Emerg Infect Dis       Date:  2017-10-17       Impact factor: 6.883

Review 6.  Bedaquiline and delamanid in the treatment of multidrug-resistant tuberculosis: Promising but challenging.

Authors:  Yang Li; Feng Sun; Wenhong Zhang
Journal:  Drug Dev Res       Date:  2018-12-11       Impact factor: 4.360

7.  Compassionate use of new drugs in children and adolescents with multidrug-resistant and extensively drug-resistant tuberculosis: early experiences and challenges.

Authors:  Marina Tadolini; Anthony J Garcia-Prats; Lia D'Ambrosio; Catherine Hewison; Rosella Centis; H Simon Schaaf; Ben J Marais; Hannetjie Ferreira; Jose A Caminero; Sylvie Jonckheere; Animesh Sinha; Krzysztof Herboczek; Zarema Khaidarkhanova; Armen Hayrapetyan; Naira Khachatryan; Ia Urtkmelidze; Carolina Loreti; Susanna Esposito; Alberto Matteelli; Jennifer Furin; Francis Varaine; Giovanni Battista Migliori
Journal:  Eur Respir J       Date:  2016-06-23       Impact factor: 16.671
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.